A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter  Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro.

Slides:



Advertisements
Similar presentations
Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,
Advertisements

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Usefulness of Endobronchial Ultrasonography With a Guide Sheath and Virtual Bronchoscopic Navigation for Ground-Glass Opacity Lesions  Yasuyuki Ikezawa,
Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations  Tae Jung Kim, MD, PhD, Choon-Taek.
Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki.
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Fate of Newly Detected Lesions During Postoperative Surveillance for Non-Small Cell Lung Cancer  Jae-Ik Lee, MD, PhD, Young-Jin Lee, RN, Kook-Yang Park,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Long-Term Outcome After Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet  Stéphane Collaud, MD, MS, Tiago Machuca, MD, PhD, Olaf Mercier,
Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer  Hiroaki Sugiura, MD, Atsuya Takeda, MD, PhD, Toshiko Hoshi, MD, PhD,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
H. Volkan Kara, MD, MS, Jeffrey Javidfar, MD, Thomas A. D’Amico, MD 
Morcellation Technique to Remove Large Tumor in Thoracoscopic Surgery
Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.
Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer  Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.
Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:
Polymorphous hemangioendothelioma
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Long-Term Survival After Salvage Surgery for Colorectal Lung Metastases  Pietro Fabio Presicci, MD, Giulia Veronesi, MD, Massimiliano D'Aiuto, MD, Lorenzo.
Surgical Repair of a Chronic Traumatic Sternal Fracture
Surgical Treatments for Multiple Primary Adenocarcinoma of the Lung
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Clinicopathologic Features of Resected Subcentimeter Lung Cancer
Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer  Aritoshi Hattori, MD,
Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma  Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,
Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer  Anthony W.
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance  Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,
Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes  Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,
The Ratio of the Maximum High Attenuation Area Dimension to the Maximum Tumor Dimension May Be an Index of the Presence of Lymph Node Metastasis in Lung.
Use of Amiodarone After Major Lung Resection
Extended Sleeve Lobectomy: One More Step Toward Avoiding Pneumonectomy in Centrally Located Lung Cancer  Jean-Philippe Berthet, MD, Marina Paradela, MD,
Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation  Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD,
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions  Hisao Asamura, MD, Kenji Suzuki,
Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact  Kenji Suzuki, MD, Masahiko.
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
High-Speed 3-Dimensional Imaging in Robot-Assisted Thoracic Surgical Procedures  Naohiro Kajiwara, MD, Soichi Akata, MD, Masaru Hagiwara, MD, Koichi Yoshida,
Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using.
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer  Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.
Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma  Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,
Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung  Yukio Watanabe, MD, Koji.
Editorial Board, January 2010
“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan  Kenji Suzuki, MD, Hisao Asamura,
Intrathoracic Multiple Schwannomas of a Single Intercostal Nerve
Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer  Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.
11C-Acetate and 18F-Fluorodeoxyglucose Positron Emission Tomography of Pulmonary Adenocarcinoma  Masahiro Kaji, MD, PhD, Hiroaki Nomori, MD, PhD, Kenichi.
The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma  Tara A. Waterman, BA, Jeffrey A. Hagen,
Transesophageal Bronchoscopic Ultrasound-Guided Fine-Needle Aspiration for Diagnosis of Peripheral Lung Cancer  Masahide Oki, MD, PhD, Hideo Saka, MD,
Philip A. Linden, MD, Jon O. Wee, MD, Michael T
Synchronous primary lung carcinoma and lung metastasis from extrathoracic carcinoma  Shinji Kanemitsu, MD, Motoshi Takao, MD, PhD, Akira Shimamoto, MD,
Trans-Arterial Infusion Chemotherapy for Recurrence of Pleural Dissemination After Thymectomy  Yasuji Terada, MD, Takatoyo Kambayashi, MD, Satomi Okahashi,
Video-Assisted Thoracoscopic Surgery for Pulmonary Nodules After Computed Tomography-Guided Marking With a Spiral Wire  Uwe Eichfeld, MD, PhD, Arne Dietrich,
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Brain Metastases Secondary to Tumor Emboli From Primary Lung Cancer During Lobectomy  Yasushi Cho, MD, Yasuhiro Hida, MD, Kichizo Kaga, MD, Hiroaki Kato,
Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer 
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma.
Mediastinal Paragangliomas: The Mayo Clinic Experience
Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma  Shinsuke.
Glomus tumor of the trachea
Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma  Hirofumi Uehara, MD,
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Tumor Thrombus in Right Atrium From Lung Adenocarcinoma
Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma  Youngkyu Moon, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer  Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.
Direct repair of giant right coronary aneurysm
Presentation transcript:

A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter  Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro Tsuboi, MD, Harubumi Kato, MD, PhD, Soichi Akada, MD, PhD, Shinya Okada, MD, PhD  The Annals of Thoracic Surgery  Volume 78, Issue 3, Pages 1011-1016 (September 2004) DOI: 10.1016/j.athoracsur.2004.03.048

Fig 1 Thin section computed tomographic scan of lung cancer depicting solid attenuation and ground-glass opacity (GGO). The largest area of tumor (solid line) and solid attenuation (dotted line) were decided based on this film. The proportion of GGO area to the entire tumor was defined; GGO ratio = (maximum GGO − maximum consolidation)/maximum GGO. Max GGO (solid arrow); Max consolidation (dotted arrow). The Annals of Thoracic Surgery 2004 78, 1011-1016DOI: (10.1016/j.athoracsur.2004.03.048)

Fig 2 Five-year survival rate of adenocarcinoma less than or equal to 2 cm was 88.0%. The Annals of Thoracic Surgery 2004 78, 1011-1016DOI: (10.1016/j.athoracsur.2004.03.048)

Fig 3 Five-year survival rate according to tumor size. Less than or equal to 1 cm = 96.7%, 1.0–1.5 cm = 81.6%, 1.5–2.0 cm = 84.4%. The Annals of Thoracic Surgery 2004 78, 1011-1016DOI: (10.1016/j.athoracsur.2004.03.048)

Fig 4 Five-year survival rate according to the proportion of ground-glass opacity (GGO) area. A GGO dominant patient indicated a 100% 5-year survival, whereas patients exhibiting a GGO area less than 50% indicated an 83.9% 5-year survival. The Annals of Thoracic Surgery 2004 78, 1011-1016DOI: (10.1016/j.athoracsur.2004.03.048)

Fig 5 Five-year survival rate according to the Noguchi classification. Noguchi A, B indicated a 100% 5-year survival, type C indicated a 97.4% 5-year survival, and types D, E, and F, indicated a 67.1% 5-year survival, respectively. The Annals of Thoracic Surgery 2004 78, 1011-1016DOI: (10.1016/j.athoracsur.2004.03.048)